Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
If a company builds assets at 8.8% a year, faster than its revenue growth rate of 3.3% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Kobayashi Pharmaceutical Co's average Total Assets Growth Rate was 2.60% per year.
During the past 3 years, the average Total Assets Growth Rate was 10.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 8.80% per year.
During the past 10 years, the average Total Assets Growth Rate was 4.90% per year.
During the past 13 years, Kobayashi Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 11.60%. The lowest was -14.50%. And the median was 4.55%.
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Kobayashi Pharmaceutical Co's Asset Turnover for the quarter that ended in Dec. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Kobayashi Pharmaceutical Co Total Assets Related Terms
Kobayashi Pharmaceutical Co Total Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co (FRA:KOY) has a Total Assets of €1,508.1 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Kobayashi Pharmaceutical Co and its competitors.
Is Kobayashi Pharmaceutical Co's Total Assets too high?
Kobayashi Pharmaceutical Co's current Total Assets is €1,508.1 Mil. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Total Assets compare to PG and CL?
Kobayashi Pharmaceutical Co's Total Assets of €1,508.1 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Total Assets is €1,508.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (FRA:KOY) has a current Total Assets of €1,508.1 Mil. The stock's GF Value™ is €30.01, compared to a current price of €28.40 — trading 5.4% below its estimated fair value. The current Total Assets is €1,508.1 Mil. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (FRA:KOY), the current Total Assets is €1,508.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (FRA:KOY) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued.
The current stock price of €28.40 is trading 5.4% below its estimated GF Value™ of €30.01.
Key valuation signals for FRA:KOY:
Total Assets: €1,508.1 Mil
GF Value™: €30.01 vs. price of €28.40 (5.4% below fair value)
No single metric tells the full story. See the FRA:KOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score
Get the complete analysis for FRA:KOY
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:KOY has been successfully added to your 
